» Authors » Tasuku Terada

Tasuku Terada

Explore the profile of Tasuku Terada including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 385
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Terada T, Hausen M, Mir H, Reed J, Coutinho T
CJC Open . 2025 Jan; 7(1):110-119. PMID: 39872645
Background: Supervised exercise programs improve walking impairment and quality of life (QoL) in patients with peripheral artery disease (PAD). However, such programs are underutilized, due to their limited accessibility. A...
2.
Vidal-Almela S, Marcal I, Wong J, Terada T, Nguyen B, Joensen A, et al.
J Cardiopulm Rehabil Prev . 2024 Sep; 44(5):E52-E63. PMID: 39240677
Purpose: Improving cardiorespiratory fitness (CRF) through exercise training is associated with lower morbidity and mortality in patients with atrial fibrillation (AF). Smaller CRF improvements have been suggested in females than...
3.
Terada T, Pap R, Thomas A, Wei R, Noda T, Visintini S, et al.
Br J Sports Med . 2024 Aug; 58(20):1225-1234. PMID: 39214675
Objective: To compare the effects of aerobic training combined with muscle strength training (hereafter referred to as combined training) to aerobic training alone on cardiovascular disease risk indicators in patients...
4.
Terada T, Keir D, Murias J, Vidal-Almela S, Buckley J, Reed J
Appl Physiol Nutr Metab . 2024 Aug; 49(12):1636-1645. PMID: 39116459
Disabling atrial fibrillation (AF)-related symptoms and different testing settings may influence day-to-day cardiopulmonary exercise testing (CPET) measurements, which can affect exercise prescription for high-intensity interval training (HIIT) and moderate-to-vigorous intensity...
5.
Reed J, Way K, ONeill C, Marcal I, Terada T
Appl Physiol Nutr Metab . 2024 Jul; 49(12):1792-1797. PMID: 38976904
Nearly 20 years have elapsed since the first clinical trial investigated the impact of interval training on patients with cardiovascular disease (CVD). This clinical corner discusses the health outcomes of...
6.
Noda T, Kamiya K, Hamazaki N, Nozaki K, Uchida S, Ueno K, et al.
J Cardiol . 2024 Jun; 84(6):355-361. PMID: 38917873
Background: Patients with heart failure (HF) often suffer from hepato-renal dysfunction. The associations between hepato-renal function changes and mortality remain unclear. Further, the effect of cardiac rehabilitation (CR) on mortality...
7.
Buckley J, Terada T, Lion A, Reed J
Eur J Appl Physiol . 2024 May; 124(10):2881-2891. PMID: 38703192
Purpose: Moderate-intensity aerobic exercise is safe and beneficial in atrial fibrillation (AF) and coronary heart disease (CHD). Irregular or rapid heart rates (HR) in AF and other heart conditions create...
8.
Noda T, Kamiya K, Hamazaki N, Yamashita M, Miki T, Nozaki K, et al.
Eur J Cardiovasc Nurs . 2024 Feb; 23(6):675-684. PMID: 38315615
Aims: SARC-F ≥ 4 points are used for detecting sarcopenia; however, finding a lower SARC-F cut-off value may lead to early detection of sarcopenia. We investigated the SARC-F score with...
9.
Noda T, Kamiya K, Hamazaki N, Nozaki K, Ichikawa T, Yamashita M, et al.
Heart Lung . 2023 Mar; 60:87-94. PMID: 36934475
Background: Patients with heart failure (HF) often exhibit signs of liver dysfunction such as high bilirubin concentrations, leading to physical dysfunction and poor prognosis. Nevertheless, the relationship between direct bilirubin...
10.
Garneau L, Terada T, Mistura M, Mulvihill E, Reed J, Aguer C
Physiol Rep . 2023 Mar; 11(5):e15634. PMID: 36905198
Low-grade inflammation is central to coronary artery disease (CAD) and type 2 diabetes (T2D) and is reduced by exercise training. The objective of this study was to compare the anti-inflammatory...